Skip to main content

medimmune-logo

AstraZeneca’s global biologics R&D arm MedImmune has entered into a five-year multi-project research collaboration with the University of Sheffield to carry out breakthrough research in cell factory technology process.

With the in cell factory technology, living cells can be controlled and manipulated to make specific proteins with therapeutic benefits.

{iframe}http://itsoftware.pharmaceutical-business-review.com/news/medimmune-sheffield-university-to-research-in-cell-factory-technology-230715-4629337{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.